.svg)
Free Testosterone: The Unbound Hormone That Cells Actually See
Free testosterone is the small portion of the hormone testosterone that circulates in blood without being attached to carrier proteins. Testosterone is produced mainly in the testes and, in smaller amounts, in the ovaries and adrenal glands. Most of it travels bound to sex hormone-binding globulin and albumin; only a small fraction is unbound. A free testosterone blood test estimates that unbound portion (free, non-protein-bound testosterone), the part that can move into tissues.
Free testosterone matters because it represents the hormone that is immediately available to act on cells. It crosses into cells, binds the androgen receptor, and turns on gene programs that support sexual function and libido, maintain muscle and bone, stimulate red blood cell production, and influence mood and energy (androgen effects). In all sexes, it helps coordinate body composition, bone strength, and reproductive health. Because it reflects the 'usable' pool rather than the total carried in the bloodstream, free testosterone offers a direct view of potential androgen activity.
Why the Unbound Fraction Matters for Androgen Signaling
Free testosterone is the small fraction not bound to carrier proteins; it enters cells and drives androgen signaling. It supports muscle and bone, red blood cell production, libido and fertility, mood and cognition, and metabolic balance.
Big picture, free testosterone sits at the junction of brain‑pituitary signals and SHBG (shaped by liver, thyroid, insulin, and estrogens), linking to bone, muscle, mood, reproduction, and long‑term metabolic and cardiovascular risk.
How a Free Testosterone Result Maps to Symptoms
Ranges differ by lab, age, and sex. Men’s values are about tenfold higher than women’s; children are low until puberty. In men, mid‑to‑upper age‑range values often feel within reference ranges; in women, lower‑to‑mid is typical. In pregnancy, SHBG rises, so free levels often stay near non‑pregnant values.
Low free testosterone reflects underactive hypothalamic‑pituitary‑gonadal signaling or relatively high SHBG. In men it brings low desire and erections, fatigue, depressed mood, less muscle, more fat, anemia, and bone loss. In women it can mean lower desire and arousal and reduced exercise capacity. In teens, sustained low values can delay puberty.
When high, androgen effects intensify. Men may develop acne, irritability, raised hematocrit, sleep apnea, prostate growth, and suppressed sperm production, especially with external androgens. In women, it often matches a polycystic ovary pattern—irregular cycles, hirsutism, acne, and insulin resistance—with fertility and cardiometabolic impact. In children, unexpectedly high values suggest early androgen exposure.
What Moves the Free Testosterone Fraction
Notes: Levels vary with age, time of day (highest in the morning), illness, and SHBG shifts (raised by estrogens, hyperthyroidism, liver disease; lowered by obesity/insulin resistance, hypothyroidism, and androgens). Pregnancy increases SHBG and total testosterone, altering free estimates. Assay method matters; equilibrium dialysis or calculated free testosterone is more reliable than direct analog immunoassays.
What a Free Testosterone Number Says About Androgen Status
The free testosterone blood test measures the small fraction of testosterone not bound to carrier proteins (mainly SHBG and albumin). This “bioactive” portion drives androgen signaling that supports energy production, muscle and bone maintenance, red blood cell formation, mood and cognition, sexual function, and aspects of metabolic and immune balance.
Low values usually reflect reduced testosterone production (testicular or ovarian/adrenal) or increased binding by SHBG, leaving too little freely available hormone. In men, this commonly shows up as lower morning energy, decreased libido and erectile quality, reduced muscle mass/strength, anemia, lower bone density, and flatter mood. In women, low free testosterone can relate to diminished sexual desire, fatigue, and lower lean mass; age and menopause lower levels naturally.
Being in range suggests adequate androgen signaling for stable body composition, libido and reproductive capacity, sustained hematopoiesis, and cognitive and metabolic resilience. When age- and sex-specific reference ranges are used, most people feel and function well across the mid portion of the range; there is no strong consensus that “optimal” sits at one extreme.
High values usually reflect increased production (endogenous or androgen exposure) or low SHBG, raising the free fraction. In men, this may present with acne/oily skin, irritability, and increased red cell mass. In women, high free testosterone often drives hirsutism, acne, scalp hair thinning, menstrual irregularity, and insulin resistance, as seen in polycystic ovary physiology.
FAQs
Free testosterone is the small portion of testosterone in the blood that is not bound to proteins and is biologically active—meaning the body can use it immediately for crucial functions like muscle growth, bone health, and sexual wellness. Only about 2–3% of total testosterone is free, but it has a powerful impact on energy, mood, libido, and overall vitality in both men and women.
Total testosterone refers to the sum of both protein-bound and unbound (free) testosterone in the bloodstream. Free testosterone, by contrast, is the unbound, "active" hormone that is available for the body to use, while most testosterone is bound to proteins like SHBG and albumin and not immediately usable.
People who have symptoms of low testosterone but normal total testosterone, those experiencing symptoms suspicious for testosterone problems, or individuals monitoring hormone therapies may benefit from measuring free testosterone. This test is particularly helpful if a healthcare provider suspects issues related to protein binding or when evaluating causes of infertility, fatigue, depression, or sexual dysfunction in both men and women.
Yes, men naturally have much higher testosterone levels than women, and reference ranges for free testosterone differ between sexes. While the hormone is vital for both, women produce smaller amounts, and high or low free testosterone can affect each group differently—for example, causing PCOS in women or hypogonadism in men.
Low free testosterone may result from aging (especially in men), testicular or ovarian dysfunction, pituitary disorders, chronic illness, increased SHBG levels, or certain medications. Symptoms often include decreased sex drive, low energy, difficulty building muscle, and mood changes.
Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.
References
- Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 103(5), 1715-1744. https://doi.org/10.1210/jc.2018-00229
- Selby, C. (1990). Sex hormone binding globulin: Origin, function and clinical significance. Annals of Clinical Biochemistry, 27(6), 532-541. https://doi.org/10.1177/000456329002700603
- Parish, S. J., Simon, J. A., Davis, S. R., Giraldi, A., Goldstein, I., Goldstein, S. W., Kim, N. N., Kingsberg, S. A., Morgentaler, A., Nappi, R. E., Park, K., Stuenkel, C. A., Traish, A. M., & Vignozzi, L. (2021). International Society for the Study of Women's Sexual Health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women. The Journal of Sexual Medicine, 18(5), 849-867. https://doi.org/10.1016/j.jsxm.2020.10.009
- Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024). Polycystic ovary syndrome. Nature Reviews Disease Primers, 10(1), 27. https://doi.org/10.1038/s41572-024-00511-3
- Gasbarrino, K., Daly, E., & Daskalopoulou, S. S. (2022). An LC-MS/MS methodological framework for steroid hormone measurement from human serum. Hormone and Metabolic Research, 54(5), 300-307. https://doi.org/10.1055/a-1768-0709
.avif)
.svg)
.svg)
